Global Cardiotoxicity Screening Market Research Report 2023
According to QYResearch’s new survey, global Cardiotoxicity Screening market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the Cardiotoxicity Screening industry include Admescope Ltd, Stemina Biomarker Discovery, Cyprotex, Eurofins Discovery, Axol Bioscience Ltd, Molecular Devices, AMRI Global, GVK Biosciences and WuXi AppTec, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cardiotoxicity Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cardiotoxicity Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiotoxicity Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Key companies engaged in the Cardiotoxicity Screening industry include Admescope Ltd, Stemina Biomarker Discovery, Cyprotex, Eurofins Discovery, Axol Bioscience Ltd, Molecular Devices, AMRI Global, GVK Biosciences and WuXi AppTec, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cardiotoxicity Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cardiotoxicity Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiotoxicity Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Admescope Ltd
- Stemina Biomarker Discovery
- Cyprotex
- Eurofins Discovery
- Axol Bioscience Ltd
- Molecular Devices
- AMRI Global
- GVK Biosciences
- WuXi AppTec
- Anbiqi Biotechnology
- Reagent
- Service
- Contract Research Organization
- Pharmaceutical Company
- Academic and Research Institutes
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiotoxicity Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reagent
1.2.3 Service
1.3 Market by Application
1.3.1 Global Cardiotoxicity Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Company
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cardiotoxicity Screening Market Perspective (2018-2029)
2.2 Cardiotoxicity Screening Growth Trends by Region
2.2.1 Global Cardiotoxicity Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiotoxicity Screening Historic Market Size by Region (2018-2023)
2.2.3 Cardiotoxicity Screening Forecasted Market Size by Region (2024-2029)
2.3 Cardiotoxicity Screening Market Dynamics
2.3.1 Cardiotoxicity Screening Industry Trends
2.3.2 Cardiotoxicity Screening Market Drivers
2.3.3 Cardiotoxicity Screening Market Challenges
2.3.4 Cardiotoxicity Screening Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cardiotoxicity Screening Players by Revenue
3.1.1 Global Top Cardiotoxicity Screening Players by Revenue (2018-2023)
3.1.2 Global Cardiotoxicity Screening Revenue Market Share by Players (2018-2023)
3.2 Global Cardiotoxicity Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiotoxicity Screening Revenue
3.4 Global Cardiotoxicity Screening Market Concentration Ratio
3.4.1 Global Cardiotoxicity Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiotoxicity Screening Revenue in 2022
3.5 Cardiotoxicity Screening Key Players Head office and Area Served
3.6 Key Players Cardiotoxicity Screening Product Solution and Service
3.7 Date of Enter into Cardiotoxicity Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CARDIOTOXICITY SCREENING BREAKDOWN DATA BY TYPE
4.1 Global Cardiotoxicity Screening Historic Market Size by Type (2018-2023)
4.2 Global Cardiotoxicity Screening Forecasted Market Size by Type (2024-2029)
5 CARDIOTOXICITY SCREENING BREAKDOWN DATA BY APPLICATION
5.1 Global Cardiotoxicity Screening Historic Market Size by Application (2018-2023)
5.2 Global Cardiotoxicity Screening Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cardiotoxicity Screening Market Size (2018-2029)
6.2 North America Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiotoxicity Screening Market Size by Country (2018-2023)
6.4 North America Cardiotoxicity Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cardiotoxicity Screening Market Size (2018-2029)
7.2 Europe Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiotoxicity Screening Market Size by Country (2018-2023)
7.4 Europe Cardiotoxicity Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cardiotoxicity Screening Market Size (2018-2029)
8.2 Asia-Pacific Cardiotoxicity Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiotoxicity Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiotoxicity Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cardiotoxicity Screening Market Size (2018-2029)
9.2 Latin America Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiotoxicity Screening Market Size by Country (2018-2023)
9.4 Latin America Cardiotoxicity Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cardiotoxicity Screening Market Size (2018-2029)
10.2 Middle East & Africa Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiotoxicity Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiotoxicity Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Admescope Ltd
11.1.1 Admescope Ltd Company Detail
11.1.2 Admescope Ltd Business Overview
11.1.3 Admescope Ltd Cardiotoxicity Screening Introduction
11.1.4 Admescope Ltd Revenue in Cardiotoxicity Screening Business (2018-2023)
11.1.5 Admescope Ltd Recent Development
11.2 Stemina Biomarker Discovery
11.2.1 Stemina Biomarker Discovery Company Detail
11.2.2 Stemina Biomarker Discovery Business Overview
11.2.3 Stemina Biomarker Discovery Cardiotoxicity Screening Introduction
11.2.4 Stemina Biomarker Discovery Revenue in Cardiotoxicity Screening Business (2018-2023)
11.2.5 Stemina Biomarker Discovery Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Detail
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Cardiotoxicity Screening Introduction
11.3.4 Cyprotex Revenue in Cardiotoxicity Screening Business (2018-2023)
11.3.5 Cyprotex Recent Development
11.4 Eurofins Discovery
11.4.1 Eurofins Discovery Company Detail
11.4.2 Eurofins Discovery Business Overview
11.4.3 Eurofins Discovery Cardiotoxicity Screening Introduction
11.4.4 Eurofins Discovery Revenue in Cardiotoxicity Screening Business (2018-2023)
11.4.5 Eurofins Discovery Recent Development
11.5 Axol Bioscience Ltd
11.5.1 Axol Bioscience Ltd Company Detail
11.5.2 Axol Bioscience Ltd Business Overview
11.5.3 Axol Bioscience Ltd Cardiotoxicity Screening Introduction
11.5.4 Axol Bioscience Ltd Revenue in Cardiotoxicity Screening Business (2018-2023)
11.5.5 Axol Bioscience Ltd Recent Development
11.6 Molecular Devices
11.6.1 Molecular Devices Company Detail
11.6.2 Molecular Devices Business Overview
11.6.3 Molecular Devices Cardiotoxicity Screening Introduction
11.6.4 Molecular Devices Revenue in Cardiotoxicity Screening Business (2018-2023)
11.6.5 Molecular Devices Recent Development
11.7 AMRI Global
11.7.1 AMRI Global Company Detail
11.7.2 AMRI Global Business Overview
11.7.3 AMRI Global Cardiotoxicity Screening Introduction
11.7.4 AMRI Global Revenue in Cardiotoxicity Screening Business (2018-2023)
11.7.5 AMRI Global Recent Development
11.8 GVK Biosciences
11.8.1 GVK Biosciences Company Detail
11.8.2 GVK Biosciences Business Overview
11.8.3 GVK Biosciences Cardiotoxicity Screening Introduction
11.8.4 GVK Biosciences Revenue in Cardiotoxicity Screening Business (2018-2023)
11.8.5 GVK Biosciences Recent Development
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Detail
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Cardiotoxicity Screening Introduction
11.9.4 WuXi AppTec Revenue in Cardiotoxicity Screening Business (2018-2023)
11.9.5 WuXi AppTec Recent Development
11.10 Anbiqi Biotechnology
11.10.1 Anbiqi Biotechnology Company Detail
11.10.2 Anbiqi Biotechnology Business Overview
11.10.3 Anbiqi Biotechnology Cardiotoxicity Screening Introduction
11.10.4 Anbiqi Biotechnology Revenue in Cardiotoxicity Screening Business (2018-2023)
11.10.5 Anbiqi Biotechnology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiotoxicity Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reagent
1.2.3 Service
1.3 Market by Application
1.3.1 Global Cardiotoxicity Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Company
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cardiotoxicity Screening Market Perspective (2018-2029)
2.2 Cardiotoxicity Screening Growth Trends by Region
2.2.1 Global Cardiotoxicity Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiotoxicity Screening Historic Market Size by Region (2018-2023)
2.2.3 Cardiotoxicity Screening Forecasted Market Size by Region (2024-2029)
2.3 Cardiotoxicity Screening Market Dynamics
2.3.1 Cardiotoxicity Screening Industry Trends
2.3.2 Cardiotoxicity Screening Market Drivers
2.3.3 Cardiotoxicity Screening Market Challenges
2.3.4 Cardiotoxicity Screening Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cardiotoxicity Screening Players by Revenue
3.1.1 Global Top Cardiotoxicity Screening Players by Revenue (2018-2023)
3.1.2 Global Cardiotoxicity Screening Revenue Market Share by Players (2018-2023)
3.2 Global Cardiotoxicity Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiotoxicity Screening Revenue
3.4 Global Cardiotoxicity Screening Market Concentration Ratio
3.4.1 Global Cardiotoxicity Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiotoxicity Screening Revenue in 2022
3.5 Cardiotoxicity Screening Key Players Head office and Area Served
3.6 Key Players Cardiotoxicity Screening Product Solution and Service
3.7 Date of Enter into Cardiotoxicity Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CARDIOTOXICITY SCREENING BREAKDOWN DATA BY TYPE
4.1 Global Cardiotoxicity Screening Historic Market Size by Type (2018-2023)
4.2 Global Cardiotoxicity Screening Forecasted Market Size by Type (2024-2029)
5 CARDIOTOXICITY SCREENING BREAKDOWN DATA BY APPLICATION
5.1 Global Cardiotoxicity Screening Historic Market Size by Application (2018-2023)
5.2 Global Cardiotoxicity Screening Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cardiotoxicity Screening Market Size (2018-2029)
6.2 North America Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiotoxicity Screening Market Size by Country (2018-2023)
6.4 North America Cardiotoxicity Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cardiotoxicity Screening Market Size (2018-2029)
7.2 Europe Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiotoxicity Screening Market Size by Country (2018-2023)
7.4 Europe Cardiotoxicity Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cardiotoxicity Screening Market Size (2018-2029)
8.2 Asia-Pacific Cardiotoxicity Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiotoxicity Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiotoxicity Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cardiotoxicity Screening Market Size (2018-2029)
9.2 Latin America Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiotoxicity Screening Market Size by Country (2018-2023)
9.4 Latin America Cardiotoxicity Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cardiotoxicity Screening Market Size (2018-2029)
10.2 Middle East & Africa Cardiotoxicity Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiotoxicity Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiotoxicity Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Admescope Ltd
11.1.1 Admescope Ltd Company Detail
11.1.2 Admescope Ltd Business Overview
11.1.3 Admescope Ltd Cardiotoxicity Screening Introduction
11.1.4 Admescope Ltd Revenue in Cardiotoxicity Screening Business (2018-2023)
11.1.5 Admescope Ltd Recent Development
11.2 Stemina Biomarker Discovery
11.2.1 Stemina Biomarker Discovery Company Detail
11.2.2 Stemina Biomarker Discovery Business Overview
11.2.3 Stemina Biomarker Discovery Cardiotoxicity Screening Introduction
11.2.4 Stemina Biomarker Discovery Revenue in Cardiotoxicity Screening Business (2018-2023)
11.2.5 Stemina Biomarker Discovery Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Detail
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Cardiotoxicity Screening Introduction
11.3.4 Cyprotex Revenue in Cardiotoxicity Screening Business (2018-2023)
11.3.5 Cyprotex Recent Development
11.4 Eurofins Discovery
11.4.1 Eurofins Discovery Company Detail
11.4.2 Eurofins Discovery Business Overview
11.4.3 Eurofins Discovery Cardiotoxicity Screening Introduction
11.4.4 Eurofins Discovery Revenue in Cardiotoxicity Screening Business (2018-2023)
11.4.5 Eurofins Discovery Recent Development
11.5 Axol Bioscience Ltd
11.5.1 Axol Bioscience Ltd Company Detail
11.5.2 Axol Bioscience Ltd Business Overview
11.5.3 Axol Bioscience Ltd Cardiotoxicity Screening Introduction
11.5.4 Axol Bioscience Ltd Revenue in Cardiotoxicity Screening Business (2018-2023)
11.5.5 Axol Bioscience Ltd Recent Development
11.6 Molecular Devices
11.6.1 Molecular Devices Company Detail
11.6.2 Molecular Devices Business Overview
11.6.3 Molecular Devices Cardiotoxicity Screening Introduction
11.6.4 Molecular Devices Revenue in Cardiotoxicity Screening Business (2018-2023)
11.6.5 Molecular Devices Recent Development
11.7 AMRI Global
11.7.1 AMRI Global Company Detail
11.7.2 AMRI Global Business Overview
11.7.3 AMRI Global Cardiotoxicity Screening Introduction
11.7.4 AMRI Global Revenue in Cardiotoxicity Screening Business (2018-2023)
11.7.5 AMRI Global Recent Development
11.8 GVK Biosciences
11.8.1 GVK Biosciences Company Detail
11.8.2 GVK Biosciences Business Overview
11.8.3 GVK Biosciences Cardiotoxicity Screening Introduction
11.8.4 GVK Biosciences Revenue in Cardiotoxicity Screening Business (2018-2023)
11.8.5 GVK Biosciences Recent Development
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Detail
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Cardiotoxicity Screening Introduction
11.9.4 WuXi AppTec Revenue in Cardiotoxicity Screening Business (2018-2023)
11.9.5 WuXi AppTec Recent Development
11.10 Anbiqi Biotechnology
11.10.1 Anbiqi Biotechnology Company Detail
11.10.2 Anbiqi Biotechnology Business Overview
11.10.3 Anbiqi Biotechnology Cardiotoxicity Screening Introduction
11.10.4 Anbiqi Biotechnology Revenue in Cardiotoxicity Screening Business (2018-2023)
11.10.5 Anbiqi Biotechnology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cardiotoxicity Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Reagent
Table 3. Key Players of Service
Table 4. Global Cardiotoxicity Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cardiotoxicity Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cardiotoxicity Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cardiotoxicity Screening Market Share by Region (2018-2023)
Table 8. Global Cardiotoxicity Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cardiotoxicity Screening Market Share by Region (2024-2029)
Table 10. Cardiotoxicity Screening Market Trends
Table 11. Cardiotoxicity Screening Market Drivers
Table 12. Cardiotoxicity Screening Market Challenges
Table 13. Cardiotoxicity Screening Market Restraints
Table 14. Global Cardiotoxicity Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cardiotoxicity Screening Market Share by Players (2018-2023)
Table 16. Global Top Cardiotoxicity Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiotoxicity Screening as of 2022)
Table 17. Ranking of Global Top Cardiotoxicity Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cardiotoxicity Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cardiotoxicity Screening Product Solution and Service
Table 21. Date of Enter into Cardiotoxicity Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cardiotoxicity Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cardiotoxicity Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Cardiotoxicity Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cardiotoxicity Screening Revenue Market Share by Type (2024-2029)
Table 27. Global Cardiotoxicity Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cardiotoxicity Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Cardiotoxicity Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cardiotoxicity Screening Revenue Market Share by Application (2024-2029)
Table 31. North America Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cardiotoxicity Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cardiotoxicity Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cardiotoxicity Screening Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 46. Admescope Ltd Company Detail
Table 47. Admescope Ltd Business Overview
Table 48. Admescope Ltd Cardiotoxicity Screening Product
Table 49. Admescope Ltd Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 50. Admescope Ltd Recent Development
Table 51. Stemina Biomarker Discovery Company Detail
Table 52. Stemina Biomarker Discovery Business Overview
Table 53. Stemina Biomarker Discovery Cardiotoxicity Screening Product
Table 54. Stemina Biomarker Discovery Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 55. Stemina Biomarker Discovery Recent Development
Table 56. Cyprotex Company Detail
Table 57. Cyprotex Business Overview
Table 58. Cyprotex Cardiotoxicity Screening Product
Table 59. Cyprotex Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 60. Cyprotex Recent Development
Table 61. Eurofins Discovery Company Detail
Table 62. Eurofins Discovery Business Overview
Table 63. Eurofins Discovery Cardiotoxicity Screening Product
Table 64. Eurofins Discovery Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 65. Eurofins Discovery Recent Development
Table 66. Axol Bioscience Ltd Company Detail
Table 67. Axol Bioscience Ltd Business Overview
Table 68. Axol Bioscience Ltd Cardiotoxicity Screening Product
Table 69. Axol Bioscience Ltd Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 70. Axol Bioscience Ltd Recent Development
Table 71. Molecular Devices Company Detail
Table 72. Molecular Devices Business Overview
Table 73. Molecular Devices Cardiotoxicity Screening Product
Table 74. Molecular Devices Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 75. Molecular Devices Recent Development
Table 76. AMRI Global Company Detail
Table 77. AMRI Global Business Overview
Table 78. AMRI Global Cardiotoxicity Screening Product
Table 79. AMRI Global Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 80. AMRI Global Recent Development
Table 81. GVK Biosciences Company Detail
Table 82. GVK Biosciences Business Overview
Table 83. GVK Biosciences Cardiotoxicity Screening Product
Table 84. GVK Biosciences Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 85. GVK Biosciences Recent Development
Table 86. WuXi AppTec Company Detail
Table 87. WuXi AppTec Business Overview
Table 88. WuXi AppTec Cardiotoxicity Screening Product
Table 89. WuXi AppTec Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 90. WuXi AppTec Recent Development
Table 91. Anbiqi Biotechnology Company Detail
Table 92. Anbiqi Biotechnology Business Overview
Table 93. Anbiqi Biotechnology Cardiotoxicity Screening Product
Table 94. Anbiqi Biotechnology Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 95. Anbiqi Biotechnology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 1. Global Cardiotoxicity Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Reagent
Table 3. Key Players of Service
Table 4. Global Cardiotoxicity Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cardiotoxicity Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cardiotoxicity Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cardiotoxicity Screening Market Share by Region (2018-2023)
Table 8. Global Cardiotoxicity Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cardiotoxicity Screening Market Share by Region (2024-2029)
Table 10. Cardiotoxicity Screening Market Trends
Table 11. Cardiotoxicity Screening Market Drivers
Table 12. Cardiotoxicity Screening Market Challenges
Table 13. Cardiotoxicity Screening Market Restraints
Table 14. Global Cardiotoxicity Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cardiotoxicity Screening Market Share by Players (2018-2023)
Table 16. Global Top Cardiotoxicity Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiotoxicity Screening as of 2022)
Table 17. Ranking of Global Top Cardiotoxicity Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cardiotoxicity Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cardiotoxicity Screening Product Solution and Service
Table 21. Date of Enter into Cardiotoxicity Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cardiotoxicity Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cardiotoxicity Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Cardiotoxicity Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cardiotoxicity Screening Revenue Market Share by Type (2024-2029)
Table 27. Global Cardiotoxicity Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cardiotoxicity Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Cardiotoxicity Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cardiotoxicity Screening Revenue Market Share by Application (2024-2029)
Table 31. North America Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cardiotoxicity Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cardiotoxicity Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cardiotoxicity Screening Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cardiotoxicity Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cardiotoxicity Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cardiotoxicity Screening Market Size by Country (2024-2029) & (US$ Million)
Table 46. Admescope Ltd Company Detail
Table 47. Admescope Ltd Business Overview
Table 48. Admescope Ltd Cardiotoxicity Screening Product
Table 49. Admescope Ltd Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 50. Admescope Ltd Recent Development
Table 51. Stemina Biomarker Discovery Company Detail
Table 52. Stemina Biomarker Discovery Business Overview
Table 53. Stemina Biomarker Discovery Cardiotoxicity Screening Product
Table 54. Stemina Biomarker Discovery Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 55. Stemina Biomarker Discovery Recent Development
Table 56. Cyprotex Company Detail
Table 57. Cyprotex Business Overview
Table 58. Cyprotex Cardiotoxicity Screening Product
Table 59. Cyprotex Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 60. Cyprotex Recent Development
Table 61. Eurofins Discovery Company Detail
Table 62. Eurofins Discovery Business Overview
Table 63. Eurofins Discovery Cardiotoxicity Screening Product
Table 64. Eurofins Discovery Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 65. Eurofins Discovery Recent Development
Table 66. Axol Bioscience Ltd Company Detail
Table 67. Axol Bioscience Ltd Business Overview
Table 68. Axol Bioscience Ltd Cardiotoxicity Screening Product
Table 69. Axol Bioscience Ltd Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 70. Axol Bioscience Ltd Recent Development
Table 71. Molecular Devices Company Detail
Table 72. Molecular Devices Business Overview
Table 73. Molecular Devices Cardiotoxicity Screening Product
Table 74. Molecular Devices Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 75. Molecular Devices Recent Development
Table 76. AMRI Global Company Detail
Table 77. AMRI Global Business Overview
Table 78. AMRI Global Cardiotoxicity Screening Product
Table 79. AMRI Global Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 80. AMRI Global Recent Development
Table 81. GVK Biosciences Company Detail
Table 82. GVK Biosciences Business Overview
Table 83. GVK Biosciences Cardiotoxicity Screening Product
Table 84. GVK Biosciences Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 85. GVK Biosciences Recent Development
Table 86. WuXi AppTec Company Detail
Table 87. WuXi AppTec Business Overview
Table 88. WuXi AppTec Cardiotoxicity Screening Product
Table 89. WuXi AppTec Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 90. WuXi AppTec Recent Development
Table 91. Anbiqi Biotechnology Company Detail
Table 92. Anbiqi Biotechnology Business Overview
Table 93. Anbiqi Biotechnology Cardiotoxicity Screening Product
Table 94. Anbiqi Biotechnology Revenue in Cardiotoxicity Screening Business (2018-2023) & (US$ Million)
Table 95. Anbiqi Biotechnology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cardiotoxicity Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cardiotoxicity Screening Market Share by Type: 2022 VS 2029
Figure 3. Reagent Features
Figure 4. Service Features
Figure 5. Global Cardiotoxicity Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cardiotoxicity Screening Market Share by Application: 2022 VS 2029
Figure 7. Contract Research Organization Case Studies
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Academic and Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Cardiotoxicity Screening Report Years Considered
Figure 12. Global Cardiotoxicity Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cardiotoxicity Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cardiotoxicity Screening Market Share by Region: 2022 VS 2029
Figure 15. Global Cardiotoxicity Screening Market Share by Players in 2022
Figure 16. Global Top Cardiotoxicity Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiotoxicity Screening as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cardiotoxicity Screening Revenue in 2022
Figure 18. North America Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 20. United States Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 24. Germany Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cardiotoxicity Screening Market Share by Region (2018-2029)
Figure 32. China Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 40. Mexico Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 44. Turkey Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Admescope Ltd Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 47. Stemina Biomarker Discovery Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 48. Cyprotex Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 49. Eurofins Discovery Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 50. Axol Bioscience Ltd Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 51. Molecular Devices Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 52. AMRI Global Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 53. GVK Biosciences Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 54. WuXi AppTec Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 55. Anbiqi Biotechnology Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Figure 1. Global Cardiotoxicity Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cardiotoxicity Screening Market Share by Type: 2022 VS 2029
Figure 3. Reagent Features
Figure 4. Service Features
Figure 5. Global Cardiotoxicity Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cardiotoxicity Screening Market Share by Application: 2022 VS 2029
Figure 7. Contract Research Organization Case Studies
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Academic and Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Cardiotoxicity Screening Report Years Considered
Figure 12. Global Cardiotoxicity Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cardiotoxicity Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cardiotoxicity Screening Market Share by Region: 2022 VS 2029
Figure 15. Global Cardiotoxicity Screening Market Share by Players in 2022
Figure 16. Global Top Cardiotoxicity Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiotoxicity Screening as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cardiotoxicity Screening Revenue in 2022
Figure 18. North America Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 20. United States Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 24. Germany Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cardiotoxicity Screening Market Share by Region (2018-2029)
Figure 32. China Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 40. Mexico Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cardiotoxicity Screening Market Share by Country (2018-2029)
Figure 44. Turkey Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cardiotoxicity Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Admescope Ltd Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 47. Stemina Biomarker Discovery Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 48. Cyprotex Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 49. Eurofins Discovery Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 50. Axol Bioscience Ltd Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 51. Molecular Devices Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 52. AMRI Global Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 53. GVK Biosciences Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 54. WuXi AppTec Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 55. Anbiqi Biotechnology Revenue Growth Rate in Cardiotoxicity Screening Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
